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Long Tube Implants in the Management of Glaucoma
A. C. B. MOLTENO, J. L. STRAUGHAN, E.ANCKER
Fig. 2. Aphakic eye with uveitis and secondary glaucoma
showing distended thick-walled bleb covering implant 41
years after operation. (Normal intra-ocular pressure and
coefficient of facility of outflow values 011 treatment.)
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envelope until it emerges behind the fornix to form a
bleb deep in the orbital tissues, where it is safe from the
risks of hypotonia rupture and infection for the patient's
lifetime (Figs 3 - 7).
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The senior author has previously reported methods of
treating severe and advanced cases of glaucoma by means
of an acrylic draining implant.'·' Subsequently we combined
this method with drug therapy to limit bleb fibrosis.' This
communication reports the results achieved in 112 patients
who were treated with a modification of the implant.
The original implant consists of an acrylic translimbal
tube which open onto the upper surface of a thin,
curved episcleral plate sutured to the anterior portion
of the globe. In most cases the initial implant provided
adequate drainage via a large, unilocular anteriorly situat-
ed bleb, formed by the action of aqueous on the tissues
covering the implant (Figs land 2).
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The design, surgical insertion and results of a plastic
draining implant for severe glaucoma are reported. The
need for pharmacological control of bleb inflammation is
stressed and the favourable long-term outlook for patients
with such implants is discussed.
Fig. 1. Diagram to show principles of original implant.
METHODS
The Implant
The modified implant consists of a translimbal tube
and an episcleral plate, but the episcleral plate is sutured
to the sclera so as to lie entirely behind the equator.
The translimbal tube, of fine-bore Silastic, enters the
deeper layers of the sclera well behind the fornix and
runs forward to enter the angle of the anterior chamber
where it is perforated to form 5 mm of 'artificial trabe-
culae'. The implant thus lies largely within the scleral
Fig. 3. Diagram to show principles of modified implant.
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At present patients are selected for insertion of implants
after it has been shown that the disease cannot be
controlled by treatment with Diamox (250 mg 4 times
per day, supplemented with potassium), eserine (0,5%
twice a day), Epitrate (I-adrenaline 2% 4 times per day),
and, in some cases, glycerol by mouth (I50 ml every 6
hours).
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Fig. 4. Implant inserted into an enucleated eye to show
perforated end of tube lying in the iridocorneal angle.
Fig. 5. Anterior scleral flap lifted to show course of
siHcone tube through deeper layers of sclera.
Indications for insertion of implants as a primary
procedure in preference to conventional surgery are still
being worked out, but so far they include advanced
buphthalmos, glaucoma secondary to uveitis, and aphakic
and thrombotic glaucoma. Implants are not used in
primary glaucoma unless the disease is terminal or con-
ventional surgery has failed.
Preparation for Operation
Four days before the operation, treatment of patients
is started with prednisone (10 mg 3 times a ilay). fluphena-
mic acid (200 mg 3 times a day), and colchicine (0,25 mg
3 times a day). This is the regimen for an adult weighing
70 kg and i administered by mouth.
Operative Technique
The operation is designed to place the perforated
portion of the tube in the angle at a tangent to the limbus,
Fig. 6. Posterior scleral flap lifted to show attachment of
silicone tube to acrylic episcleral plate.
Fig. 7. Acrylic episcleral plate sutured to posterior portion
of globe, showing zig-zag incision through outer three-
quarters of the sc.lera.
so as to avoid injury to the corneal endothelium, and to
place the tube in the deepe t layers of the sclera. Early
extrusion is avoided by placing the suture lines away
from the tube.
Exposure of the superonasal quadrant of the globe is
obtained by an incision into the conjunctiva and Tenon's
capsule, from the superior rectus insertion to below and
anterior to the medial rectus insertion.
After bleeding vessels have been cauterised and the sclera
has been cleaned up to the limbus, a turn-point midway
between the uperior and medial rectus insertions and 7
mm from the limbu is marked with a cautery, and two
triangular flaps of c1era are di sected up. The incision
for the anterior flap extend from the turn-point along
the anterior border of the medial rectu insertion to its
inferior limit and then radially forward to the limbus,
but not into the anterior chamber. The flap is raised by
splitting the deepest layers of sclera until it ba e extend
from the turn-point along a tangent to the limbu (Fig. 5).
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Tbe incision for tbe posterior flap extends from the
turn-point to the medial margin of the superior rectus
mu cle and then back to the equator of the globe. This
flap is also raised by splitting the deeper layers of the
sclera until its base tretche radially back from the turn-
point to the equator of the globe (Fig 6 and 7).
The episcleral plate of the implant is sutured to the
sclera by mean of two anterior holes only, the tube is
laid along the base of the posterior flap, and the fiap is
sutured back into position. The tube is laid along the
base of the anterior flap to select the point of entry into
tbe anterior chamber.
After a stab incision through the limbal tissues, the
tube i fed into the anterior chamber (iridectomy is not
necessary). If correctly placed the perforated portion of
the tube will occupy the inferonasal portion of the angle
(Fig. 4). If entangled by the iris, tbe tube is freed by
means of Ringer's solution syringed down the lumen, and
the scleral flaps are firmly closed by multiple interrupted
non-absorbable sutures (6,0 or 7,0 silk).
Tenon's capsule is drawn forward and sutured to tbe
anterior flap of sclera by 2 or 3 interrupted sutures, and
after closure of the conjunctiva by a continuous suture
of 7,0 silk, the operation is completed by subconjunctival
injection of a mixture of cephalosporin. gentamicin and
methylprednisolone.
Postoperative Management
As a routine all patients are treated systemically .for
6 weeks with prednisone 10 mg 3 times a day (for 70-kg
adult), fluphenamic acid 200 mg 3 times a day, and
colchicine 0,25 mg 3 times a day. Epitrate 2% drops 4
times per day, atropine I o~ drops twice daily, and Sofradex
drops 4 times per day are applied topically for 6 weeks.
This regimen blocks most of the known mediators of
tbe inflammatory response. Prednisone has a wide range
of actions which include stabilisation of cell membranes
and inhibition of kinin formation. Flupbenamic acid blocks
prostaglandin synthesis while colchicine blocks the
hydroxylation of proline and thereby prevents the con-
version of procollagen into collagen.'
Epitrate counteracts the action of the enzyme catechol
O-methyltransferase which is increased in inflamed tissues;
atropine blocks the effects of tbe vasodilator acetylcholine'
while Sofradex contains the fluorinated prednisone deri-
vative dexamethasone, which is an anti-inflammatory
steroid with the side-effect of inducing atrophy of connec-
tive ti sue. This regimen was administered meticulously
for 6 weeks, while all the patients, except those who could
be trusted to treat themselves, were hospitalised. These
agents exhibit a very marked synergism in reducing bleb
inflammation and thus limiting deposition of fibrous tissue
around the episcleral plates of implants.
RESULTS
Local Complications
These were difficult to define with certainty owing
to the advanced stage of the disease in the eyes selected
for implants. However, the following complications were
definitely ascribable to the implants:
(i) corectopia (due to iris becoming attached to the
tube in the angle) was significant in 6 eyes but
caused no visual deficit;
(ii) exposure of tube occurred in 3 of the earlier cases,
before suitable scleral flaps were devised to over-
come this problem; in 2 patients the sclera was
resutured, in the third a preserved scleral graft was
used to bury the tube;
(iii) tube blockage - where new blood vessels extended
into the tube end - occurred in 2 patients with
thrombotic glaucoma;
(iv) vitreous strands entered the tube in 8 instances,
but have not interfered with drainage so far;
(v) endophthalmitis developed in I patient and was
successfully treated, but it left an unduly thick
bleb with poor drainage;
TABLE I. RESULTS OF INSERTION OF LONG TUBE IMPLANTS IN 64 PATIENTS
(18 MONTHS TO 3 YEARS FOLLOW-UP)
Diagnosis
Primary open-angle glaucoma
Infantile
Juvenile
Adult
Chronic closed angle glaucoma
Glaucoma secondary to congenital
displaced lenses
Infantile
Juvenile
Adult
Glaucoma secondary to uveitis
Thrombotic glaucoma
Cure (lOP 20 Control (lOP 20 Failure (lOP 20
mmHg and mmHg on treatment mmHg and
CO = 0,15) and Co 0,15) Co = 0,15)
5 1
2 3
6 2
2
defects, surgery, trauma,
3 5
2 4 1
11 4 2
3 1
4 2
32 26 6
lOP - intra-ocular pressure; Co - coefficient of outflow.
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(vi) the iris occluded the tube in 4 cases, where it was
placed too deeply in the iridocorneal recess; in 3
cases the tube end was surgically removed and
reinserted without complications, In the fourth a
second implant was inserted.
Systemic Complications
The combination of prednisone, f1uphenamic acid and
colchicine administered by mouth caused remarkably few
side-effects, considering the potencies and actions of the
drugs. Gastric discomfort was the commonest side-effect
and was observed in 8 patients. It was avoided by giving
medication after meals and was readily treated with ora)
antacids, without the necessity of stopping treatment.
Perforation of a pre-exl tmg peptic ulcer occurred in )
patient. Diabetes was unmasked in 2 patients by the use
of steroids, while an Addisonian crisis occurred in 1
patient who developed pneumonia 5 weeks after dis-
continuing drugs to suppress fibrosis.
Over-all Results
We have performed 112 long tube implant operations
over the last 3 years. Of 64 patients who have been
followed-up for more than 18 months the present status
is as follows: 32 are cured, in 26 the glaucoma is under
control, and in 6 the operation failed (Table I).
Details of our first 24 patients (with more than 2"1-
years follow-up) are summarised in Table If.
TABLE 11. DETAILS OF AESULTS IN 24 PATIENTS (30 EYES) (2"1- - 3 YEAAS' FOLLOW-UP)
Before operation
(on drug treatment) Aher operation
26 (A) }
27 (L)
28
29 (A) }
30 (L)
8 (A) }
9 (L)
10 (A) }
11 (L)
12 (A) }
13 (L)
14
15
16
17
18
19
20
21
22
23
24
25
Eye
1
2
3
4
5 (A)
6 (L)
7
}
Age
of
patient
25
55
59
33
44
10
34
32
64
69
4
57
42
61
43
13
22
46
48
61
47
-51
58
16
Diagnosis
OAG
Aphakic
Aphakic
OAG
Trauma
Trauma
Juvenile
glaucoma
(12 previous
operations)
Trauma
Trauma
OAG
OAG
OAG
OAG
Aphakic
Buphthalmos
Aphakic
Thrombotic
Aphakic
Uveitis
Aniridia
OAG
Aphakic
APhakic
Aphakic
Chron. angle
closure
OAG
OAG
Uveitis
Buphthalmos
Buphthalmos
lOP
(mmHg)
45
42
27
38
30
38
45
35
50
38
33
33
38
42
48
43
60
30
38
33
60
28
45
50
82
28
30
45
38
33
C·
0,003
0,008
0,05
0,10
0,06
0,06
0,002
0,06
0,06
0,11
0,13
0,08
0,09
0,04
0,01
0,03
0,00
0,10
0,09
0,08
0,04
Vision
PL
PL
6/8
6/5
CF2m
CF2 m
3/60
CF2m
6/60
CF3 m
6/12
6/9
6/6
PL
PL
CF3m
HMl m
PL
PL
PL
No PL
6/20
HM 1 m
PL
PL
CF2 m
6/40
6/60
PL
No PL
lOP
16
15
20
20
15
19
25
16
22
16
17
24
22
16
15
22
35
14
17
16
22
17
16
18
30
15
14
14
20
10
C·
0,38
0,23
0,23
0,24
0,18
0,24
0,16
0,19
0,16
0,33
0,27
0,26
0,24
0,17
0,16
0,11
0,20
0,15
0,47
0,25
0,58
0,20
0,28
0,24
0,18
Vision
PL
CF2m
6/18
6/5
CF2 m
CF2 m
2/60
CF2m
6/36
CF3m
6/12
6/9
6/6
PL
No PL
CF3m
CF3 m
PL
PL
PL
NoPL
6/20
HMl m
HMlm
6/9
CF2 m
6/40
6/18
PL
No PL
Drug
therapy
Nil
Nil
Nil
E
Nil
Nil
P, E
P, E
P, E
D, P, E
D,P,E
Nil
Nil
Nil
Nil
Nil
E*
Nil
E
E
E
D, E
Nil
Nil
Et
Nil
Nil
E
E, D
E, D
co - coefficient of outflow; CF - counting fingers; 0 - Diamox: E - Epitrate: HM - hand movements; lOP - intra·ocular pressure;
GAG - open-angle glaucoma; P - pilocarpine: PL - perception of light.
* Implant operations done twice.
t Surgical complication.
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DISCUSSIO
Precise indications for long tube implants are still being
inve tigated, but at present several definite indications are
recognised:
In buphthabnos which is too advanced for goniotomy,
gratifying results have been obtained with the long tube
implant.
In glaucoma due to smouldering uveitis, anterior-type
implants gave good results but the long-term use of
teroids to control uveitis usually caused undue thinning
of blebs, with danger of perforation: The new implants
are easier to insert and the long-term prognosis is much
better, since steroids can be used without danger of
expo ing the deeply buried implants.
Traumatic g1aucomas, aphakic gJaucomas, and neglected
cases of angle-closure glaucoma form a mixed group, which
includes buphthalmos and uveitis, and pose very difficult
surgical problems. Implants are, however, indicated where
conventional surgery seems hopeless, especially in young
patients (Tables I and Il).
Thrombotic glaucoma is another indication for long tube
implants. The earlier anterior implants drained thrombotic
glaucomas for a few months only before becoming blocked
by new blood vessels invading the lumen of the tube~
Our experience with 5 patients, who retained vision for
the 3 - 10 months during which the intra-ocular pressure
was controlled, suggested that it was worth while to treat
this condition. So far, 7 eyes have been drained by long
tube implants. The problem of new vessels which rapidly
clogged the side end of the tube was overcome by using
a simple open-ended tube and performing an iridectomy
to keep new vessels away from the tube. The eyes of all
7 patients remain pain-free, with intra-ocular pre~sures
varying from 10 to 40 mmHg on Epitrate alone (follow-up
6 month to 21 years).
We have described the use of implants with suppression
of fibrosis in desperate cases where no other treatment
seemed likely to be effective. However, long tube implants
worked magnificently in advanced cases of primary
glaucoma, whether buphthalmos, juvenile or adult types
In such relatively normal phakic eyes they are inserted
easily and without trauma. In addition, fibrosis suppression
is less important in elderly patients and can be reduced
somewhat, so that in patients over 40 years old with
primary glaucomas one can almost guarantee that intra-
ocular pressure will be controlled without hypotensive
medication and without much risk of serious side-effects.
Long-Term Outlook
The development of blebs over implants has been
observed in detail in 180 anterior implants, both by serial
slit lamp photography and by histological examination of
biopsy and autopsy material.
An initial subacute inflammatory reaction led to the
formation of a thick-walled fibrovascular bleb, lined by
an inner membrane of avascular fibrous tissue. Degeneration
of this layer began approximately 3 months after the
operation, the collagen gradually swelled and lost its
staining properties, while the fibroblast nuclei became
pyknotic and then disappeared. The inner fibrous layer
became thinner and eventually disappeared approximately
5 years after insertion of the implant. Lymphatics were
first noticed 18 months after operation and became
gradually more numerous and prominent - while in
ome cases new aqueous veins appeared abruptly in the
deeper layers of the bleb. These changes, accompanied
by a gradual fall in intra-ocular pressure and increase
in outflow, have been followed for up to 5 years in many
cases, and in 2 eyes for 7 years.
The long tube implants behave in a similar fashion
insofar as intra-ocular pressure is concerned, while 4
histological specimens which were available confirmed
that the bleb histology was identical to that of anteriorly
situated blebs.
A patient in whom a bronchogenic carcinoma developed
after insertion of a long tube implant, provided a clear
demonstration of the roles of fibrous tissue, Iymphatics
and the episcleral veins in bleb function. The carcinoma
caused rapid wasting of body connective tissue, including
that of the bleb, as well as slowly increasing obstruction
of the superior vena cava. During the last 5 months of
life the patient's coefficient of facility of outflow rose
from CO = 0,23 to CO = 0,53, while at the same time his
intra-ocular pressure rose from 11 to 18 mmHg. These
findings can be interpreted as loss of fibrous tissue, causing
an improved outflow, at the same time as increasing supe-
rior vena-caval obstruction which caused elevation of
episcleral venous pressure and hence of intra-ocular
pressure.
At present 54 patients with anterior implants, inserted
during 1970 - 1972, and 93 patients with long tube implants,
inserted from January 1973 to September 1975, attend
regularly for follow-up at intervals of 3 - 6 months.
Continuous follow-up of these patients has shown that
the long-term result of these implants is a gradual fall
in intra-ocular pressure, until the decay of fibrous tissue
with the development of Iymphatics and new aqueous
veins has advanced to the stage where essentially free
communication exists between the bleb cavity and the
episcleral venous system. In these circumstances the intra-
ocular pressure is likely to remain very slightly higher
than the episcleral venous pressure (8 - 12 mmHg), without
the need for hypotensive medication for the rest of the
patient's life.
We should like to thank: the trustees of the Willem Goosen
Trust Fund for money used to buy equipment.
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